Great pick up!
And logic would entail if the SubB2M Prostate & Pancreatic results are also excellent like the Breast/Ovarian results, then I have confidence Bard1 will continue to expand the SubB2M technology across all main cancers. Lung etc.
SubB2M may be able to efficiently detect all types of cancer. If it can detect Breast & Ovarian will 100& or 95% accuracy then there is definitely a good chance it will be able to detect most types of cancer.
The upside here is ginormous, how are we still at sub $500m market cap.
- Forums
- ASX - By Stock
- Pending testing results
Great pick up!And logic would entail if the SubB2M Prostate &...
-
- There are more pages in this discussion • 91 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IIQ (ASX) to my watchlist
|
|||||
Last
57.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $63.40M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 37420 | 56.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
58.0¢ | 10000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 37420 | 0.560 |
3 | 23800 | 0.555 |
6 | 80050 | 0.550 |
1 | 1500 | 0.530 |
1 | 1400 | 0.525 |
Price($) | Vol. | No. |
---|---|---|
0.580 | 10000 | 1 |
0.590 | 6499 | 1 |
0.600 | 19543 | 4 |
0.610 | 6129 | 1 |
0.630 | 5000 | 1 |
Last trade - 10.05am 15/08/2024 (20 minute delay) ? |
Featured News
IIQ (ASX) Chart |
Day chart unavailable
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online